SLACK DAVID W. (President & CBO) received a stock award from LISATA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/11/2023ACC: 0001943584-23-000002
DirectorOfficer· President & CBO
Since Sep 2022
+32.64K
Net shares
Net buyer
$10.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
36K acquired · 3.36K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+24K
Price / share
—
Trade value
—
% of position
New position
1/9/2023
0.00→24K
Common Stock
Direct
Shares
−3.36K
Price / share
$3.00
Trade value
$10.07K
% of position
14.0%
1/9/2023
24K→20.64K
Total
Net shares
+20.64K
Net value
-$10.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2023 | A · Award | +24K | — | — | New position | 0.00 | 24K |
| Common Stock Direct | 1/9/2023 | F · Tax Withholding | −3.36K | $3.00 | $10.07K | 14.0% | 24K | 20.64K |
| Total | +20.64K | -$10.07K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
12K shares
Shares
+12K
Strike price
3.0
Held after
12K
Exercisable
—
1/9/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock12K shares | 1/9/2023 | A · Award | +12K | 3.0 | — | 12K |